Continued Committee Member Employer/Title Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational or Other Financial Benefit Expert Witness Voting Recusals by Section* Laura Mauri Brigham & Women s Hospital Associate Professor of Medicine, Harvard Medical School  Medtronic  St. Jude Medical None None None  Abbott  Boston Scientific  Bristol-Myers Squibb  Cordis  Medtronic Cardiovascular  Sanofi-aventis None and Roxana Mehran Columbia University Medical Center Associate Professor of Medicine; Director, Data Coordinating Analysis Center  Abbott Vascular  Boston Scientific  Janssen (Johnson & Johnson)  Merck  Sanofi-aventis None None  BMS/Sanofi- aventis  Regado  STENTYS None None and Issam D. Moussa University of Central Florida College of Medicine Professor of Medicine; First Coast Cardiovascular Institute Chief Medical Officer None None None None None None None Debabrata Mukherjee Texas Tech University Chief, Cardiovascular Medicine None None None None None None None Henry H. Ting New York Presbyterian Hospital, The University Hospital of Columbia and Cornell Senior Vice President and Chief Quality Officer None None None None None None None This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of of the voting stock or share of the business entity, or ownership of of the fair market value of the business entity; or if funds received by the person from the business entity exceed of the person s gross income for the previous year. 